Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Kamada submits inhaled AAT phase III protocol to FDA for review

July 21, 2017

European Commission approves Veltassa to treat hyperkalemia

July 21, 2017

Otsuka Pharmaceutical Factory identifies lipoprotein lipase activators

July 21, 2017

Shionogi & Co. patents MGAT2 inhibitors

July 21, 2017

FDA grants tentative approval for follow-on biologic basal insulin Lusduna Nexvue

July 21, 2017

PreveCeutical enters research and option agreement with UniQuest in diabetes and obesity

July 19, 2017

REDX-05194 ameliorates diabetic nephropathy in mice by reducing inflammasome activation

July 18, 2017

Proellex to remain on partial clinical hold

July 18, 2017

FDA issues complete response letter for Evenity for postmenopausal osteoporosis

July 17, 2017

NIH grant supports Crinetics' development of CRN-00808 for acromegaly

July 17, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...